144 related articles for article (PubMed ID: 23712969)
1. Proteomic approach toward molecular backgrounds of drug resistance of osteosarcoma cells in spheroid culture system.
Arai K; Sakamoto R; Kubota D; Kondo T
Proteomics; 2013 Aug; 13(15):2351-60. PubMed ID: 23712969
[TBL] [Abstract][Full Text] [Related]
2. Ca
Ohya S; Kajikuri J; Endo K; Kito H; Elboray EE; Suzuki T
Cancer Sci; 2021 Sep; 112(9):3769-3783. PubMed ID: 34181803
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteome analysis of monolayer and spheroid culture of canine osteosarcoma cells.
Gebhard C; Miller I; Hummel K; Neschi Née Ondrovics M; Schlosser S; Walter I
J Proteomics; 2018 Apr; 177():124-136. PubMed ID: 29337282
[TBL] [Abstract][Full Text] [Related]
4. Proteome analysis of responses to ascochlorin in a human osteosarcoma cell line by 2-D gel electrophoresis and MALDI-TOF MS.
Kang JH; Park KK; Lee IS; Magae J; Ando K; Kim CH; Chang YC
J Proteome Res; 2006 Oct; 5(10):2620-31. PubMed ID: 17022633
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of osteosarcoma.
Bernardini G; Laschi M; Geminiani M; Santucci A
Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells.
Gaedtke L; Thoenes L; Culmsee C; Mayer B; Wagner E
J Proteome Res; 2007 Nov; 6(11):4111-8. PubMed ID: 17918984
[TBL] [Abstract][Full Text] [Related]
7. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix.
Harisi R; Dudás J; Tímár F; Pogány G; Paku S; Tímár J; Kovalszky I; Szendroi M; Jeney A
Anticancer Res; 2005; 25(2A):805-13. PubMed ID: 15868912
[TBL] [Abstract][Full Text] [Related]
9. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma.
Kubota D; Mukaihara K; Yoshida A; Tsuda H; Kawai A; Kondo T
J Proteomics; 2013 Oct; 91():393-404. PubMed ID: 23911960
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
11. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Luk F; Yu Y; Walsh WR; Yang JL
Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
[TBL] [Abstract][Full Text] [Related]
12. Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma.
Nathan SS; DiResta GR; Casas-Ganem JE; Hoang BH; Sowers R; Yang R; Huvos AG; Gorlick R; Healey JH
Clin Cancer Res; 2005 Mar; 11(6):2389-97. PubMed ID: 15788690
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy resistance in osteosarcoma: current challenges and future directions.
Chou AJ; Gorlick R
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1075-85. PubMed ID: 16831079
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional cell organization leads to a different type of ionizing radiation-induced cell death: MG-63 monolayer cells undergo mitotic catastrophe while spheroids die of apoptosis.
Indovina P; Rainaldi G; Santini MT
Int J Oncol; 2007 Dec; 31(6):1473-83. PubMed ID: 17982674
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry imaging of endogenous metabolites in response to doxorubicin in a novel 3D osteosarcoma cell culture model.
Palubeckaitė I; Crooks L; Smith DP; Cole LM; Bram H; Le Maitre C; Clench MR; Cross NA
J Mass Spectrom; 2020 Apr; 55(4):e4461. PubMed ID: 31654532
[TBL] [Abstract][Full Text] [Related]
16. ABCB1-overexpressing MG63/DOX cell xenograft model: maintain the MDR phenotype in vivo.
Zhou Z; Wan L; Han Y; Meng X; Yang Q; Li Y; Yu Q; Shen Z; Guo C
Pharm Biol; 2013 Aug; 51(8):968-73. PubMed ID: 23735077
[TBL] [Abstract][Full Text] [Related]
17. Salinomycin inhibits osteosarcoma by targeting its tumor stem cells.
Tang QL; Zhao ZQ; Li JC; Liang Y; Yin JQ; Zou CY; Xie XB; Zeng YX; Shen JN; Kang T; Wang J
Cancer Lett; 2011 Dec; 311(1):113-21. PubMed ID: 21835542
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets.
Folio C; Mora MI; Zalacain M; Corrales FJ; Segura V; Sierrasesúmaga L; Toledo G; San-Julián M; Patiño-García A
J Proteome Res; 2009 Aug; 8(8):3882-8. PubMed ID: 19492781
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of zoledronic acid against human osteosarcoma cells.
Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W
J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
